IRCT201306189175N5CompletedPhase 2
Comparison of therapeutic effect of bupropion and venlafaxine in children with Attention deficit hyperactivity disorder
Vice chancellor for research, Mashhad University of Medical Sciences0 sites40 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- Enrollment
- 40
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 7 years to 10 years (—)
- Sex
- All
Inclusion Criteria
- •Children with attention deficit hyperactivity disorder between 7 to 10 years old with IQ more than 70 by Rion quiz and have not any psychiatric and neurological problem at interview.
- •Exclusion criteria: Children with attention deficit hyperactivity disorder lower than 7 years old and more than 10 years old, IQ lower than 70 and any psychiatric and neurological problem at interview.
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Completed
Not Applicable
Comparing the effects of Bupropion and Buprenorphine on the reduction of Methamphetamine cravingMethamphetamine Dependency.Mental and behavioural disorders due to use of other stimulants, including caffeine : dependence syndromeF 15.2IRCT2015010320540N1Vice Chancellor for research of Shiraz University of Medical Sciences60
Recruiting
Phase 2
Comparison of bupropion, fluoxetine, and methylphenidate in cancer-related fatigueIRCT20180623040193N3Shahre-kord University of Medical Sciences60
Active, not recruiting
Not Applicable
Clinical evaluation study: Bupropion versus Psychodynamic mental training according to Dr. Grohs for smoke withdrawal(Klinische Evaluierungsstudie: Bupropion versus Psychodynamisches Mentaltraining nach Dr. Grohs zur Raucherentwöhnung - Bupropion vs. PDM zur RaucherentwöhnungEUCTR2005-006189-32-ATSteiermärkische Gebietskrankenkasse
Not yet recruiting
Phase 2
To Compare Two different Doses Of Drug Buprenorphine By Giving Block (Regional Anesthesia) and see for its Analgesic action and pain relief post operative periodCTRI/2020/06/026126Dr Dnyaneshwari Munde
Not yet recruiting
Phase 3
Comparing how two different doses of an additive to bupivacaine heavy modifies the duration of action when used in lower limb surgeriesCTRI/2022/01/039545Dr Ashik Sreekumar